Hansa Biopharma achieves Great Place to Work[®] certification for the third consecutive year
· Award granted by internationally recognized Great Place to Work[®] institute. · Certification based on company-wide survey completed by 99% of Hansa employees. · Metrics related to trust in the company, credibility, pride and fairness, continue to be among those most highly rated by employees.Lund, Sweden, September 30, 2022. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announced its certification as a Great Place to Work[®] 2022, awarded by the Great Place to Work[®] institute, an independent and